Innovation seen in transcatheter aortic valve replacement

Great strides are being made in the treatment of heart disease with innovative new treatment options for valvular heart disease. Since 2007, I’ve had the privilege of serving on a team of Emory physicians that has helped revolutionize the treatment of severe aortic stenosis, leading the national effort to study and advance a new nonsurgical procedure called transcatheter aortic valve replacement or TAVR. Aortic stenosis is a dangerous heart condition that affects tens of thousands of Americans…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news